about
Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's DiseaseThe Role of Amyloid-β Oligomers in Toxicity, Propagation, and ImmunotherapyCalcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's DiseaseAlzheimer's Disease: Mechanism and Approach to Cell TherapyTransient dynamics of Aβ contribute to toxicity in Alzheimer's diseasePreclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s DiseaseIndividual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells.The antibody aducanumab reduces Aβ plaques in Alzheimer’s diseaseThe stability of cylindrin β-barrel amyloid oligomer models-a molecular dynamics study.Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties.Ortho-methylated 3-hydroxypyridines hinder hen egg-white lysozyme fibrillogenesis.A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses.Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob diseaseThe elusive nature and diagnostics of misfolded Aβ oligomers.Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.Amyloid β-mediated Zn2+ influx into dentate granule cells transiently induces a short-term cognitive deficit.Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons.Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes.Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models.CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease.Allosteric stabilization of the amyloid-β peptide hairpin by the fluctuating N-terminal.Computational modeling of the relationship between amyloid and disease.Neutron Scattering Studies of the Interplay of Amyloid β Peptide(1-40) and An Anionic Lipid 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol.Revisiting rodent models: Octodon degus as Alzheimer's disease model?ER-stress in Alzheimer's disease: turning the scale?Mitochondrial dysfunction and oxidative stress in aging and cancer.S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice modelIron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.Regulation of extracellular Zn(2+) homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease.New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Proteotoxicity and cardiac dysfunction.The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.TREM2 in Neurodegenerative Diseases.An Account of Amyloid Oligomers: Facts and Figures Obtained from Experiments and Simulations.Advantages of Structure-Based Drug design Approaches in Neurological Disorders.Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143-Further Implications for Alzheimer's TherapyAggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?Potential mechanisms and implications for the formation of tau oligomeric strains.The road to restoring neural circuits for the treatment of Alzheimer's disease.
P2860
Q26738450-C137D8F4-4B21-4FE4-996A-53F7976A2896Q26747107-642E0F38-4E8C-4B86-9CE8-2EE2813E0628Q26747527-BD266552-E262-4F84-9942-BC525EF76D08Q26778149-FF931FD0-2B42-4A0D-990E-45422B60396DQ26827421-D0D6FA4D-48C1-431A-B48F-67B76732B272Q27305174-CF6CE660-6E04-4160-B8A5-C27A0AC8054DQ27315920-5F95492C-E785-4E9D-B7D9-7ED13DC26631Q28005463-DC235729-1BC4-441A-BC89-D70BD58B0951Q30155110-6CC27005-0484-4418-B8DE-AF0B311CF78DQ30364908-936AD04A-492D-487A-A8D5-BB53879714D8Q30376637-8B9118DE-80F8-423F-96E1-60E0AC4C70EEQ30827953-3B56BAED-CEC3-4582-958D-54D9118EF965Q33612558-91124CC3-0087-43A2-94AE-2B36749F6EACQ35194588-7F1958CB-03DE-4903-A2DC-70ED8DD4AFD9Q35327172-95B92CCD-2C63-4EC9-993D-7012FE305AD9Q35533112-1C94ADB1-810B-4B52-97E8-57F9099BB35EQ35646336-D15C97CF-1E18-420E-A450-F7EA330C23CCQ35696876-BDC39B41-4739-42D6-B754-501D35F927DEQ35837187-C8552459-53D4-40B6-A50D-937036D28562Q36169215-196AC910-BC4A-42E7-B4B3-0C36FB26E4DAQ36240389-5CFD4A99-DD32-4EC7-9DB2-336697B202D2Q36484002-6C71E772-0DA0-48EA-A430-BBF15CAE5C6DQ36677013-37F32A9F-F574-4B25-BBFF-E9626C446C94Q37199192-389B804E-6DED-4121-ADCA-A67371E1AAA7Q37212020-8715F100-EDFE-42CE-A260-0A78E52EC465Q37366999-62911FF4-28A0-45E0-B1F4-7D24149EA778Q37564295-28F48C86-108D-4BCD-B1AC-93E1C015B67DQ37603519-FF41B13B-D8C7-4389-BC58-875D1693B017Q38186783-3A95181D-8887-46F4-A7E6-EE86DD0366E3Q38394521-3BC47CCB-00B1-4736-B4B4-3C6152A0AF3BQ38395251-A7AB126E-A0B1-4F82-86D7-B69B86328775Q38497014-DB56B040-D990-4CF2-ACA7-9490A75D208FQ38520167-236265B5-396B-4561-B442-261A4ACDB1D6Q38646212-D09951FA-0176-4E61-8806-460D8424DED2Q38748337-22FEA859-9B81-4EDC-B36B-196742CF9EE0Q38775661-AA66684A-DD96-4F88-BE66-29AABA02678AQ38803172-9DFEB5B1-7893-4E78-9972-728046553205Q38934098-6873DC2C-CE42-4A3E-B5C6-56805DA90164Q38960046-7FEDDEB8-84B1-4C84-A2BD-BC7976AD5E03Q39004340-88E4BF91-DCF7-4FD5-A563-2F64F75E9309
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular mechanisms of amyloid oligomers toxicity.
@en
type
label
Molecular mechanisms of amyloid oligomers toxicity.
@en
prefLabel
Molecular mechanisms of amyloid oligomers toxicity.
@en
P356
P1476
Molecular mechanisms of amyloid oligomers toxicity.
@en
P2093
Cristian A Lasagna-Reeves
Rakez Kayed
P304
P356
10.3233/JAD-2012-129001
P478
33 Suppl 1
P577
2013-01-01T00:00:00Z